News

Researchers have used AI to identify previously unknown compounds in some of Earth's oldest microbial lifeforms that could have applications in developing next-generation antibiotics.

Research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block COVID-19 from infecting human cells, reducing infection rates by nearly 99%.

A new AI model can design and optimize drug candidate molecules tailored to a protein’s structure alone – without needing prior information about binding molecules.

A research team at McMaster University has discovered a new drug class that could someday lead to treatments for dangerous fungal infections. The new molecules, dubbed coniotins, were isolated from a plant-dwelling fungus.

New research has pinpointed how a parasitic worm that causes schistosomiasis suppresses neurons in the skin to evade detection.

Two new solutions can help alleviate inflammation associated with the use of lipid nanoparticles in RNA therapies, while still getting RNA where it needs to be in the cell.

Targeting cellular structures called nuclear speckles could be a completely new approach for treating proteinopathies, including Alzheimer's, Parkinson's and prion diseases.

Researchers surveyed 58 directors of hospital-based addiction consult services (ACS) and found that most ACS recognized the prevalence of high-potency synthetic opioids and agreed they have changed how they approach medication initiation.

Researchers found that MYCN located on extra-chromosomal DNA enables some neuroblastoma cells to enter a dormant, therapy-resistant state. Combining chemotherapy with drugs targeting senescent cells removed aggressive and dormant cells in models.

A new book reveals that elite athletes face distinct depression risks despite exercise’s protective effects. Pressures such as performance demands, injury fears and career transitions can undermine mental health.